BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8477058)

  • 1. Treatment of standard risk acute lymphoblastic leukemia in children with the Tokyo Children Cancer Study Group (TCCSG) L84-11 protocol in Japan.
    Tsukada M; Komiyama A; Nakazawa S; Tsuchida M; Nishihira H; Shitara T; Ohira M; Tsunematsu Y; Yamamoto K; Hoshi Y
    Int J Hematol; 1993 Jan; 57(1):1-7. PubMed ID: 8477058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T
    Int J Hematol; 1994 Feb; 59(2):99-112. PubMed ID: 8018909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Okamura J; Ishii E; Ikuno Y; Koga H; Eguchi H; Yanai F; Inada H; Nibu K; Hara T; Take H; Miyazaki S; Tasaka H
    Pediatr Hematol Oncol; 1999; 16(3):187-99. PubMed ID: 10326217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL; Chen YC; Kao WY; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ; Blatt J; Sather HN; Meadows AT
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center].
    de Diego-Floreschapa J; López-Hernández M; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1999; 135(3):253-8. PubMed ID: 10425822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
    Tsuchida M; Ohara A; Manabe A; Kumagai M; Shimada H; Kikuchi A; Mori T; Saito M; Akiyama M; Fukushima T; Koike K; Shiobara M; Ogawa C; Kanazawa T; Noguchi Y; Oota S; Okimoto Y; Yabe H; Kajiwara M; Tomizawa D; Ko K; Sugita K; Kaneko T; Maeda M; Inukai T; Goto H; Takahashi H; Isoyama K; Hayashi Y; Hosoya R; Hanada R;
    Leukemia; 2010 Feb; 24(2):383-96. PubMed ID: 20033052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
    Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
    Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
    Kikuchi A; Maeda M; Hanada R; Okimoto Y; Ishimoto K; Kaneko T; Ikuta K; Tsuchida M;
    Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
    J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.